Dr. Robert Whitfield cites JAMA research and testing of 694 explant capsules that found 29% contamination with chemicals like atrazine and organophosphates. He argues measuring toxic burden before and after surgery reveals clues to chronic illness and introduces his SHARP method to address gaps in standard care.
This is all published material in the Journal of the American Medical Association. And in our patients, we have testing over and over again that reveals data like atrazine, like organophosphate. Published the largest PCR-tested explant capsule series in the world. Shows 29% contamination rate in 694 consecutive samples. You know, we're constantly looking at and evaluating heavy metals and mycotoxins. I don't think there are many clinics like ours measuring toxic burden in the entire world. We think it's very important before surgery, and I hang my hat on it after surgery as well. I see what's been affecting patients to give me clues about why they may have other issues that develop chronically or that they just have to work through over time. The SHARP method for me, uh, helped fill in those gaps. Looking at genetics, looking at toxicity burden, gut health, food sensitivities, hormonal balance, all those things that were outside of the standard purview. There are some specific steps you can take to measure your toxic burden and start reducing it.
